The Swiss Biotech Association’s Nic Alexakis describes Switzerland’s thriving biotech scene and extensive support infrastructure, while also highlighting the gaps around early stage funding and the ability of different cantons to collaborate on economic development.
Switzerland of course has quite the reputation as a hub for biotech activity – how competitive is the country amongst the world’s leading biotech hubs?
"Switzerland has now made it into the ‘premier league’ of biotech hubs in the world, alongside Boston/Cambridge and California in the US, Oxford/Cambridge in the UK, and the German, French, and Dutch biotech communities."
